Dimethyl Fumarate Treatment for Intracranial Unruptured Aneurysms.
Condition(s):Intracranial Aneurysm; Aneurysm, Brain; Inflammation VascularLast Updated:July 25, 2023Not yet recruiting
Include Studies Not Open or Pending
Condition(s):Intracranial Aneurysm; Aneurysm, Brain; Inflammation VascularLast Updated:July 25, 2023Not yet recruiting
Condition(s):Multiple SclerosisLast Updated:November 15, 2023Recruiting
Condition(s):Acute Ischemic StrokeLast Updated:June 6, 2022Recruiting
Condition(s):Age-related Macular Degeneration (AMD)Last Updated:August 3, 2022Recruiting
Condition(s):Multiple SclerosisLast Updated:April 24, 2023Recruiting
Condition(s):Multiple SclerosisLast Updated:November 18, 2023Not yet recruiting
Condition(s):Multiple SclerosisLast Updated:February 29, 2024Recruiting
Condition(s):Multiple SclerosisLast Updated:December 14, 2023Recruiting
Condition(s):Multiple Sclerosis, Relapsing-RemittingLast Updated:March 1, 2024Recruiting
Condition(s):Severe Acute Respiratory SyndromeLast Updated:January 5, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.